Varian Medical Systems Inc. (VAR)

118.81
NYSE : Health Technology
Prev Close 120.84
Day Low/High 118.08 / 121.61
52 Wk Low/High 101.42 / 130.29
Avg Volume 757.90K
Exchange NYSE
Shares Outstanding 91.12M
Market Cap 11.01B
EPS 1.60
P/E Ratio 74.59
Div & Yield N.A. (N.A)

Latest News

HollandPTC Opens With ProBeam System From Varian

HollandPTC Opens With ProBeam System From Varian

PALO ALTO, Calif., Nov.

Varian Halcyon Treatment System Receives China NMPA Approval

Varian Halcyon Treatment System Receives China NMPA Approval

PALO ALTO, Calif., Nov.

Anat Ashkenazi Named To Varian Board Of Directors

Anat Ashkenazi Named To Varian Board Of Directors

PALO ALTO, Calif., Nov.

Varian To Present At The Citi Global Healthcare Conference

Varian To Present At The Citi Global Healthcare Conference

PALO ALTO, Calif., Nov.

Varian Publishes 2018 Sustainability Report

Varian Publishes 2018 Sustainability Report

PALO ALTO, Calif., Nov.

Beijing Cancer Hospital Utilizes Varian RapidPlan To Win IDC Digital Transformation Award

Beijing Cancer Hospital Utilizes Varian RapidPlan To Win IDC Digital Transformation Award

PALO ALTO, Calif. and BEIJING, Nov.

Varian Reports Results For Fourth Quarter And Full Fiscal Year 2018

Varian Reports Results For Fourth Quarter And Full Fiscal Year 2018

PALO ALTO, Calif., Oct.

Varian Unveils New Bravos Afterloader System For Brachytherapy Treatments

Varian Unveils New Bravos Afterloader System For Brachytherapy Treatments

PALO ALTO, Calif., Oct.

Varian Forms FlashForward Consortium To Study Ultra-high Dose Rate Cancer Treatments With Protons

Varian Forms FlashForward Consortium To Study Ultra-high Dose Rate Cancer Treatments With Protons

Consortium focused on preclinical research, clinical implementation and advocacy

Varian Introduces New ProBeam 360° Proton Therapy System

Varian Introduces New ProBeam 360° Proton Therapy System

PALO ALTO, Calif., Oct.

Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition

Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition

PALO ALTO, Calif., Oct.

Varian Signs Educational Partnerships With Reliance Group In India

Varian Signs Educational Partnerships With Reliance Group In India

Varian Advanced Radiotherapy Clinical School Established at Group's Flagship Hospital in Mumbai

Varian Appoints New Division Presidents

Varian Appoints New Division Presidents

Veteran Varian Leaders Kolleen T. Kennedy and Chris Toth Step into New Roles

Varian Shares Vision Of A World Without Fear Of Cancer

Varian Shares Vision Of A World Without Fear Of Cancer

Company publishes "The Future of Cancer Care: Moving from Promise to Reality"

Dr. Jeff Balser Named To Varian Board Of Directors

Dr. Jeff Balser Named To Varian Board Of Directors

PALO ALTO, Calif., Sept.

Epic Sciences Announces Completion Of $52 Million Series E Financing

Epic Sciences Announces Completion Of $52 Million Series E Financing

Proceeds will be used to advance liquid biopsy tests to predict drug response in cancer patients and to integrate company's No Cell Left Behind platform with electronic medical records and big data analytics

Varian Signs Partnership Agreement With Mediheal To Support Cancer Care In Kenya

Varian Signs Partnership Agreement With Mediheal To Support Cancer Care In Kenya

PALO ALTO, Calif. and NAIROBI, Kenya, Sept.

Varian To Present At Baird Global Healthcare Conference

Varian To Present At Baird Global Healthcare Conference

PALO ALTO, Calif., Aug.

Varian CEO Dow Wilson Joins USISPF Board Of Directors

Varian CEO Dow Wilson Joins USISPF Board Of Directors

PALO ALTO, Calif., Aug.

Varian Announces Acquisition Of HumediQ Global GmbH

Varian Announces Acquisition Of HumediQ Global GmbH

Acquisition expands Varian's motion-management portfolio and presence in Germany

Varian Reports Results For Third Quarter Of Fiscal Year 2018

Varian Reports Results For Third Quarter Of Fiscal Year 2018

Third Quarter 2018 Summary

TheStreet Quant Rating: B+ (Buy)